Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Jun 8:12:130.
doi: 10.1186/1471-2334-12-130.

HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis

Xun Zhuang  1 , Yanxian Liang, Eric P F Chow, Yafei Wang, David P Wilson, Lei Zhang
Affiliations
Meta-Analysis

HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis

Xun Zhuang et al. BMC Infect Dis. .

Abstract

Background: Methadone maintenance treatment (MMT) was implemented in China since 2004. It was initiated in 8 pilot clinics and subsequently expanded to 738 clinics by the end of 2011. Numerous individual research studies have been conducted to estimate HIV and HCV prevalence among MMT clients but an overview of the epidemics in relations to MMT remains unclear. The aim of this study is to estimate the magnitude and changing trends of HIV, HCV and HIV-HCV co-infections among entry clients to MMT clinics in China during 2004-2010.

Methods: Chinese and English databases of literature were searched for studies reporting HIV, HCV and co-infection prevalence among MMT clients in China from 2004 to 2010. The prevalence estimates were summarized through a systematic review and meta-analysis of published literatures.

Results: Ninety eligible articles were selected in this review (2 in English and 88 in Chinese). Nationally, pooled prevalence of HIV-HCV and HIV-HCV co-infection among MMT clients was 6.0% (95%CI: 4.7%-7.7%), 60.1% (95%CI: 52.8%-67.0%) and 4.6% (95%CI: 2.9%-7.2%), respectively. No significant temporal trend was found in pooled prevalence estimates. Study location is the major contributor of heterogeneities of both HIV and HCV prevalence among drug users in MMT.

Conclusions: There was no significant temporal trend in HIV and HCV prevalence among clients in MMT during 2004-2010. Prevalence of HCV is markedly higher than prevalence of HIV among MMT clients. It is recommended that health educational programs in China promote the earlier initiation and wider coverage of MMT among injecting drug users (IDUs), especially HIV-infected IDUs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart showing the meta-analysis studies selection. N; the number of articles included in systematic review; n, the number of prevalence estimates included in meta-analysis.
Figure 2
Figure 2
The regional distribution of pooled prevalence of (a) HIV infection; (b) HCV infection; and (c) HIV-HCV co-infection in MMT in China.
See this image and copyright information in PMC

References

    1. YanPing B, ZhiMin L. Current situation and trends of drug abuse and HIV/AIDS in China. HIV Therapy. 2009;3(3):237–240.
    1. Liu Z, Lian Z, Zhao C. Drug use and HIV/AIDS in China. Drug Alcohol Rev. 2006;25:173–175. - PubMed
    1. Zhang L, Yap L, Xun Z, Wu Z, Wilson D. Needle and syringe programs in Yunnan, China yield health and financial return. BMC Public Health. 2011;11(1):250. - PMC - PubMed
    1. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China, 2003. 2003.
    1. Zhu QY. Analysis of data AIDS sentinel surveillance from 1996 to 2003 in Guangxi province. CHIN J AIDS STD. 2006;12(5):290–432.

Publication types